
Leidos Hld (LDOS) Stock Forecast & Price Target
Leidos Hld (LDOS) Analyst Ratings
Bulls say
Leidos Holdings Inc. has demonstrated substantial growth and profitability, particularly in its Health & Civil segment, which has benefited from increased exam volumes, driving margins due to operational scale. The company's national security revenues surged 8% year-over-year to $2.02 billion, attributed to new contract awards and growth in defense IT services, while defense systems revenues saw an even more pronounced 11% increase to $582 million. Furthermore, the earnings before interest and taxes (EBIT) margins have shown remarkable improvement, escalating from 14.5% in 2023 to 22.5% in 2024, with half-year 2025 projections reflecting continued strength at 24.3%.
Bears say
Leidos Holdings Inc. faces a challenging outlook primarily due to anticipated declines in profit margins in the second half of 2025 compared to the first half, raising concerns about overall financial performance. The potential decrease in medical exam volumes, particularly in its managed health services segment, poses additional risks that could further pressure margins and negatively impact investor sentiment. Moreover, external factors such as protests against contract wins, uncertainties surrounding defense spending influenced by recent stimulus measures, and risks associated with international operations add to the pressures on the company's financial stability.
This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.
Leidos Hld (LDOS) Analyst Forecast & Price Prediction
Start investing in Leidos Hld (LDOS)
Order type
Buy in
Order amount
Est. shares
0 shares